Gastroesophageal Cancer in Older Adults with Frailty
Frailty in Older Adults with Cancer, Page: 403-419
2022
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Gastro-oesophageal cancer is an age-related illness; over 50% of patients are diagnosed over the age of 75. Given this age demographic and associations with obesity and smoking patients often live with chronic health conditions and varying degrees of frailty. The multidisciplinary team needs to factor in evidence of frailty when planning patient management. For early cancers endoscopic options may be considered in preference to surgery and for those with more locally advanced disease radiotherapy options may be considered. Age alone should not preclude an optimal approach including both chemotherapy and surgery for appropriately selected and counselled patients with potentially curative disease. Frailty is however a key consideration in this decision-making process. For those older patients with frailty diagnosed with more advanced disease, dose adjusted chemotherapy is recommended but for some patients, supportive care alone may be advisable. This chapter presents a review of the most suitable treatment options for the sub-group of older adults with frailty diagnosed with gastro-oesophageal cancer, from an early stage to a metastatic setting.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85153644900&origin=inward; http://dx.doi.org/10.1007/978-3-030-89162-6_23; https://link.springer.com/10.1007/978-3-030-89162-6_23; https://dx.doi.org/10.1007/978-3-030-89162-6_23; https://link.springer.com/chapter/10.1007/978-3-030-89162-6_23
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know